Clinical Trial Detail

NCT ID NCT01434316
Title Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Dinaciclib + Veliparib

Veliparib

Age Groups: adult senior

No variant requirements are available.